The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance
Review of 32 studies (nearly 50,000 participants) evaluating the TG/HDL ratio as a low-cost surrogate marker of insulin resistance across populations.
Evidence
—
Not Rated
Sample
—
subjects
Duration
—
study period
Journal
Biomedicines
Jul 2024
Structured Methods
- Study Design
- Systematic Review
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Not reported
Citations & References
Unknown authors (2024). The Triglyceride/HDL Ratio as a Surrogate Biomarker for Insulin Resistance. Biomedicines. https://doi.org/10.3390/biomedicines12071493
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
